Showing 8481-8490 of 21414 results for "".
The Treatment of Transplant Patients With Diabetes
https://reachmd.com/programs/diabetes-discourse/the-treatment-of-transplant-patients-with-diabetes/6291/Fifty percent of patients living with diabetes will require some sort of renal replacement therapy. What percent will go on to renal transplantation and what are the recommendations for the management of these patients? Join host Dr. Steven Edelman and his guest, transplant dietitian at the UniversiFacing Formidable Diabetic Cases with Patient Persistence & Adherence
https://reachmd.com/programs/diabetes-discourse/facing-formidable-diabetic-cases-with-patient-persistence-adherence/12088/How can we encourage patients with diabetes to persist and adhere to treatment?Managing Diabetes During the COVID-19 Pandemic
https://reachmd.com/programs/diabetes-discourse/managing-diabetes-during-the-covid-19-pandemic/12265/What are some challenges that come with managing diabetes during the COVID-19 pandemic and how can we overcome them?2000 Steps a Day May Keep Diabetes At Bay
https://reachmd.com/programs/diabetes-discourse/2000-steps-a-day-may-keep-diabetes-at-bay/13636/A new study shows that taking just 2000 steps a day can help reduce the risk of diabetes. What do we need to know about these findings—and how can we implement them in our practice?Addressing Cost-Related Medication Non-Adherence in Diabetes
https://reachmd.com/programs/diabetes-discourse/cost-nonadherence-diabetes/57026/Cost-related medication nonadherence remains a significant but often hidden barrier to effective diabetes care, with out-of-pocket costs preventing patients from accessing essential therapies. Dr. Kimberly Narain joins us to explain why clinicians should look beyond insurance status alone and considEfficacy and Safety of Finerenone in Patients With Non-Diabetic CKD: Insight From FIND-CKD
https://reachmd.com/clinical-practice/nephrology/efficacy-and-safety-of-finerenone-in-patients-with-non-diabetic-ckd-insight-from-find-ckd/49256/Explore efficacy and safety data from the FIND-CKD study, presented at ERA 2026, on the use of finerenone in patients with non-diabetic CKD.Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
https://reachmd.com/programs/cme/continuous-glucose-and-ketone-monitoring-making-smarter-decisions-in-diabetes/68957/Interpretation of CGM data from the ambulatory glucose profile (AGP), is vital for the optimal application of CGM your clinical practice. Recognizing the impact of DKA in diabetes and the role of ketone monitoring in detecting and managing DKA in patients who are at higher risk is required for patieThe Highs and Lows of Managing Diabetes in Teenagers
https://reachmd.com/programs/focus-on-diabetes/the-highs-and-lows-of-managing-diabetes-in-teenagers/3841/For teenage diabetic populations, maintaining good glycemic control is often a low priority. Clinicians and families need to be aware of special considerations in this age group to ensure better control and reduce risk for postpubertal complication. How do physicians optimize management protocols foATTRv vs ATTRwt: Hereditary and Wild-Type ATTR-CM
https://reachmd.com/programs/spotlight-attr-cm/hereditary-attrv-vs-wild-type-attrwt-attr-cm/68947/Managing Diabetes & COVID-19 in the Wintertime
https://reachmd.com/programs/diabetes-discourse/managing-diabetes-covid-19-in-the-wintertime/12061/How are clinicians going above and beyond to keep patients with diabetes safe from COVID-19 and other threats during the winter months?